Real-world Study Assessing Efficacy of TezepeLumaB in Patients With Severe Asthma Regardless of Phenotype in Russia
NCT06566885 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 125
Last updated 2026-05-12
Summary
ELBRUS is a 12-month (52-week), multi-centre, prospective, non-comparative and non-interventional (observational), post-reimbursement real-world evidence study that will assess patient-reported outcomes after tezepelumab treatment initiation in participants with severe asthma in Russia.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-10
- Primary Completion
- 2026-09-30
- Completion
- 2026-09-30
Countries
- Russia
Study Locations
More Related Trials
-
Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma
NCT03347279 ·Status: COMPLETED ·Phase: PHASE3
-
Patient Characteristics, Treatment Patterns and Outcomes of Patients With Severe Asthma Treated With Tezepelumab in the Real World; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma Centres
NCT06455462 ·Status: COMPLETED
-
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Adults With Inadequately Controlled Asthma With High Bronchodilator Reversibility
NCT01902290 ·Status: TERMINATED ·Phase: PHASE2
-
TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)
NCT05729711 ·Status: ACTIVE_NOT_RECRUITING
-
Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.
NCT06473779 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With Asthma
NCT04673630 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study
NCT06521229 ·Status: RECRUITING
-
Real World Evidence of Benralizumab in Eosinophilic Severe AsThma in Russia (BEST)
NCT05271526 ·Status: COMPLETED
-
Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients
NCT05603845 ·Status: COMPLETED
-
Observational Retrospective Study To Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab in the Framework Of Use in Special Situations Prior to Commercialisation in Spain
NCT06487065 ·Status: COMPLETED
-
STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma
NCT06465485 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma
NCT00189722 ·Status: COMPLETED ·Phase: PHASE2
-
Change in Patient-Reported Outcomes in Severe Eosinophilic Asthma Patients Treated With Benralizumab Under Real-life Conditions
NCT04184284 ·Status: COMPLETED
-
Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA
NCT06020014 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Safety and Efficacy of SelK2 on Airway Responses Following Allergen Challenge in Subjects With Asthma (Part 1) and in Subjects With Chronic Obstructive Pulmonary Disease (Part 2)
NCT04540042 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)
NCT06472310 ·Status: RECRUITING
-
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
NCT01508936 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults & Adolescents With OCS Dependent Asthma
NCT02281357 ·Status: COMPLETED ·Phase: PHASE3
-
Single Dose Study of the Fluticasone/Salmeterol (500/50 μg) Administered With Elpenhaler® Versus Diskus®
NCT01484210 ·Status: COMPLETED ·Phase: PHASE3
-
Non-interventional Retrospective Multicenter Study of Patients With Bronchial Asthma During a Routine Visit to Out of Patients' Clinics
NCT01273363 ·Status: COMPLETED
-
Patient-reported Outcomes in Real-world Use of Benralizumab in Patients With Severe Eosinophilic Asthma in Belgium
NCT04221802 ·Status: COMPLETED
-
A Study to Test if TEV-48574 is Effective in Relieving Asthma
NCT04545385 ·Status: TERMINATED ·Phase: PHASE2
-
A Study for Observing Severe Asthma in Patients Treated With Tezepelumab
NCT05677139 ·Status: COMPLETED
-
A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication
NCT01868061 ·Status: COMPLETED ·Phase: PHASE3
-
Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Biologic Therapy, a Post Authorization Safety Study
NCT04991805 ·Status: COMPLETED